Mankind Pharma Limited has allotted 23,256 equity shares to eligible employees under its Employee Stock Option Plan (ESOP) 2022. The decision was approved by the company’s Nomination and Remuneration Committee on March 16, 2026, reflecting the company’s continued effort to reward employees and align their interests with long-term business growth. The allotment slightly increases the company’s total paid-up share capital and strengthens its employee ownership program.

 

Author : Aashiya Jain | EQmint | Corporate Updates

 

Mankind Pharma Issues Shares Under ESOP Plan

Mankind Pharma Limited recently announced the allotment of 23,256 equity shares to employees who exercised their stock options under the Mankind Employee Stock Option Plan (ESOP) 2022. The allotment was approved through a circular resolution by the company’s Nomination and Remuneration Committee on March 16, 2026.

 

The shares carry a face value of ₹1 per equity share and are issued to employees who had previously been granted options under the company’s ESOP scheme. Once exercised, these options convert into equity shares, giving employees a direct stake in the company’s performance and future growth.

 

The newly issued shares will rank pari-passu with the existing equity shares, meaning they will carry the same rights and privileges as other shares already listed in the market.

 

Impact on Share Capital

Following this allotment, the company’s paid-up equity share capital has increased slightly. Before the allotment, Mankind Pharma had 41,28,05,072 equity shares outstanding. After issuing the new shares, the total number of shares increased to 41,28,28,328 equity shares, each with a face value of ₹1.

 

According to the details provided in the official filing, the exercise price for the ESOP shares is ₹860 per share, with a premium of ₹859 per share.

 

These shares are listed on both major Indian stock exchanges the National Stock Exchange (NSE) and BSE Limited, allowing employees who receive the shares to benefit from the company’s market performance over time.

 

Purpose of Employee Stock Option Plans

Employee Stock Option Plans are commonly used by organizations to motivate their employees. This is done by providing employees with stock options, which allow them to become partial owners of the company.

 

The benefits of an ESOP to employees are that they can earn financial benefits from the company if it performs well. On the other hand, organizations use employee stock option plans as a retention strategy to keep their employees engaged in the company’s growth trajectory.

 

The Mankind Pharma ESOP Plan 2022 has been implemented with similar objectives.

 

About Mankind Pharma

Mankind Pharma Limited is one of the leading pharmaceutical companies in India, recognized for the manufacture and supply of a broad range of affordable healthcare products. Since its establishment in 1995, Mankind Pharma has emerged to become one of the prominent pharmaceutical companies in India, offering a broad range of pharmaceutical products in various therapeutic areas, including antibiotics, gastrointestinal, cardiovascular, and anti-infectives, among others.

 

Besides being a prominent pharmaceutical company, Mankind Pharma is also recognized for its popular consumer healthcare products, including Manforce condoms, Prega News pregnancy test kits, and Gas-O-Fast digestive solutions. With a clear commitment to the supply of accessible and affordable healthcare products, Mankind Pharma has become renowned for the supply of quality healthcare solutions to millions of consumers.

Strengthening Employee Participation

The latest ESOP share allotment indicates the company’s strategy for building an organization that is focused on people. The idea is to encourage employees to be more innovative and productive by providing them a sense of ownership in the company’s success.

 

Although the shares allotted in this round are fewer in comparison to the overall share base, such initiatives are significant for building employee engagement.

 

In the context of the growth and development of the pharmaceutical industry, initiatives such as ESOPs are not only about rewarding employees but also about building a motivated workforce for the company.

 

For more such information visit EQMint

Resource Link: NSE

 

Disclaimer:  This article is not an investment advice and is for educational purpose only